Search | Page 20 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. North American Pediatric Aplastic Anemia Consortium Symposium

    ... in the particularly difficult distinction of SAA from refractory cytopenia of childhood (RCC), a subtype of ...

    Page last updated 10/31/2013 - 4:06pm.

  2. Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

    ... AML in second or subsequent complete remission. MDS: refractory anemia with excess blasts (RAEB), or chronic ...

    Clinical Trial last updated 04/28/2016 - 2:08pm.

  3. Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

    ... recently completed a pilot study of eltrombopag in refractory SAA. We saw encouraging clinical results in a cohort of patients ...

    Clinical Trial last updated 04/25/2016 - 2:47pm.

  4. Clinical Trials Report for January 2015

    ... pharmacokinetics of TEN-010 in patients with relapsed/ refractory acute myeloid leukemia (RR-AML) and hypomethylating agent (HMA)-refractory myelodysplastic syndrome (MDS). In addition, this trial will assess ...

    Page last updated 12/30/2014 - 10:45am.

  5. Clinical Trials Report for March 2015

    ... of TEN-010 in patients with relapsed/ refractory acute myeloid leukemia (RR-AML) and hypomethylating agent (HMA)-refractory myelodysplastic syndrome (MDS). In addition, this trial will assess ... cohorts of three or more patients with RR-AML or HMA-refractory MDS will be treated at escalating doses until a maximum tolerated ...

    Page last updated 03/02/2015 - 10:06am.

  6. What MDS Patients Should Know About Clinical Trials

    ... therapies that didn’t’ work for them? We call this refractory MDS, where there was no improvement after 4 or 6 months, or ...

    Interview last updated 11/13/2015 - 11:12am.

  7. Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... stem cell transplantation (HSCT) or MM patients with refractory disease who may benefit from tandem autologous-nonmyeloablative ...

    Clinical Trial last updated 04/29/2016 - 3:26pm.

  8. Acute Myeloid Leukemia (AML)

    ... present after the patient finishes standard therapy ( refractory leukemia):  There may be a different approach to treatment than ...

    Topic section last updated 07/07/2016 - 3:15pm.

  9. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... failed immunosuppressive therapy         3) Refractory anemia (RA) or RARS MDS patients who have associated transfusion ...

    Clinical Trial last updated 04/28/2016 - 2:40pm.

  10. Clinical Trials Report for April 2015

    ... pharmacokinetics of TEN-010 in patients with relapsed/ refractory acute myeloid leukemia (RR-AML) and hypomethylating agent (HMA)-refractory myelodysplastic syndrome (MDS). In addition, this trial will assess ...

    Page last updated 03/30/2015 - 11:40am.